651 related articles for article (PubMed ID: 25996949)
21. The Ubiquitin Sensor and Adaptor Protein p62 Mediates Signal Transduction of a Viral Oncogenic Pathway.
Wang L; Howell MEA; Sparks-Wallace A; Zhao J; Hensley CR; Nicksic CA; Horne SR; Mohr KB; Moorman JP; Yao ZQ; Ning S
mBio; 2021 Oct; 12(5):e0109721. PubMed ID: 34488443
[TBL] [Abstract][Full Text] [Related]
22. Characterization of Target Gene Regulation by the Two Epstein-Barr Virus Oncogene LMP1 Domains Essential for B-cell Transformation.
Mitra B; Beri NR; Guo R; Burton EM; Murray-Nerger LA; Gewurz BE
bioRxiv; 2023 Oct; ():. PubMed ID: 37090591
[TBL] [Abstract][Full Text] [Related]
23. The c-Jun N-terminal kinase pathway is critical for cell transformation by the latent membrane protein 1 of Epstein-Barr virus.
Kutz H; Reisbach G; Schultheiss U; Kieser A
Virology; 2008 Feb; 371(2):246-56. PubMed ID: 17967471
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr virus latent membrane protein 1 modulates distinctive NF- kappaB pathways through C-terminus-activating region 1 to regulate epidermal growth factor receptor expression.
Kung CP; Raab-Traub N
J Virol; 2010 Jul; 84(13):6605-14. PubMed ID: 20410275
[TBL] [Abstract][Full Text] [Related]
25. Global Proteomic Changes Induced by the Epstein-Barr Virus Oncoproteins Latent Membrane Protein 1 and 2A.
DeKroon RM; Gunawardena HP; Edwards R; Raab-Traub N
mBio; 2018 Jun; 9(3):. PubMed ID: 29921667
[TBL] [Abstract][Full Text] [Related]
26. The Latent Membrane Protein 1 (LMP1).
Kieser A; Sterz KR
Curr Top Microbiol Immunol; 2015; 391():119-49. PubMed ID: 26428373
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of latent membrane protein 1 impairs the growth and tumorigenesis of latency II Epstein-Barr virus-transformed T cells.
Ndour PA; Brocqueville G; Ouk TS; Goormachtigh G; Morales O; Mougel A; Bertout J; Melnyk O; Fafeur V; Feuillard J; Coll J; Adriaenssens E
J Virol; 2012 Apr; 86(7):3934-43. PubMed ID: 22258264
[TBL] [Abstract][Full Text] [Related]
28. The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation.
Izumi KM; Kaye KM; Kieff ED
Proc Natl Acad Sci U S A; 1997 Feb; 94(4):1447-52. PubMed ID: 9037073
[TBL] [Abstract][Full Text] [Related]
29. Requirement for LMP1-induced RON receptor tyrosine kinase in Epstein-Barr virus-mediated B-cell proliferation.
Chou YC; Lin SJ; Lu J; Yeh TH; Chen CL; Weng PL; Lin JH; Yao M; Tsai CH
Blood; 2011 Aug; 118(5):1340-9. PubMed ID: 21659546
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus LMP2A reduces hyperactivation induced by LMP1 to restore normal B cell phenotype in transgenic mice.
Vrazo AC; Chauchard M; Raab-Traub N; Longnecker R
PLoS Pathog; 2012; 8(4):e1002662. PubMed ID: 22536156
[TBL] [Abstract][Full Text] [Related]
31. Activation of the canonical IKK complex by K63/M1-linked hybrid ubiquitin chains.
Emmerich CH; Ordureau A; Strickson S; Arthur JS; Pedrioli PG; Komander D; Cohen P
Proc Natl Acad Sci U S A; 2013 Sep; 110(38):15247-52. PubMed ID: 23986494
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.
Eliopoulos AG; Stack M; Dawson CW; Kaye KM; Hodgkin L; Sihota S; Rowe M; Young LS
Oncogene; 1997 Jun; 14(24):2899-916. PubMed ID: 9205097
[TBL] [Abstract][Full Text] [Related]
33. Molecular mechanisms of TNFR-associated factor 6 (TRAF6) utilization by the oncogenic viral mimic of CD40, latent membrane protein 1 (LMP1).
Arcipowski KM; Stunz LL; Graham JP; Kraus ZJ; Vanden Bush TJ; Bishop GA
J Biol Chem; 2011 Mar; 286(12):9948-55. PubMed ID: 21262968
[TBL] [Abstract][Full Text] [Related]
34. Cooperation between TNF receptor-associated factors 1 and 2 in CD40 signaling.
Xie P; Hostager BS; Munroe ME; Moore CR; Bishop GA
J Immunol; 2006 May; 176(9):5388-400. PubMed ID: 16622006
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus LMP1 inhibits the expression of SAP gene and upregulates Th1 cytokines in the pathogenesis of hemophagocytic syndrome.
Chuang HC; Lay JD; Hsieh WC; Wang HC; Chang Y; Chuang SE; Su IJ
Blood; 2005 Nov; 106(9):3090-6. PubMed ID: 16002423
[TBL] [Abstract][Full Text] [Related]
36. Roles of TRAF2 and TRAF3 in Epstein-Barr virus latent membrane protein 1-induced alternative NF-kappaB activation.
Song YJ; Kang MS
Virus Genes; 2010 Oct; 41(2):174-80. PubMed ID: 20585848
[TBL] [Abstract][Full Text] [Related]
37. Frequent expression of the tumor necrosis factor receptor-associated factor 1 in latent membrane protein 1-positive posttransplant lymphoproliferative disease and HIV-associated lymphomas.
Murray PG; Swinnen LJ; Flavell JR; Ragni MV; Baumforth KR; Toomey SM; Filipovich AH; Lowe D; Schnell CS; Johl J; Gulley M; Young LS; Ambinder RF
Hum Pathol; 2001 Sep; 32(9):963-9. PubMed ID: 11567226
[TBL] [Abstract][Full Text] [Related]
38. The role of hybrid ubiquitin chains in the MyD88 and other innate immune signalling pathways.
Cohen P; Strickson S
Cell Death Differ; 2017 Jul; 24(7):1153-1159. PubMed ID: 28475177
[TBL] [Abstract][Full Text] [Related]
39. The Epstein-Barr virus latent membrane protein 1 putative Janus kinase 3 (JAK3) binding domain does not mediate JAK3 association or activation in B-lymphoma or lymphoblastoid cell lines.
Higuchi M; Kieff E; Izumi KM
J Virol; 2002 Jan; 76(1):455-9. PubMed ID: 11739714
[TBL] [Abstract][Full Text] [Related]
40. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family.
Mosialos G; Birkenbach M; Yalamanchili R; VanArsdale T; Ware C; Kieff E
Cell; 1995 Feb; 80(3):389-99. PubMed ID: 7859281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]